Clinical Trials Browser

Phase 2 × Serotonin Syndrome × Clear all

NCT05361668 2026-03-19

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Phase 2 Completed

36 enrolled 19 charts

EndocrineNET

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

NCT03453489 2025-04-10

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Phase 2 Completed

4 enrolled 7 charts

Serotonin Syndrome

NCT04713202 2023-02-10

NET-PACS

Phase 2 Withdrawn

EndocrineNET

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT03722511 2022-11-03

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Phase 2 Completed

10 enrolled

EndocrineNET

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT04776876 2021-09-29

Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome

Phase 2 Withdrawn

Serotonin Syndrome

NCT04039516 2020-08-04

CHARRT

Phase 2 Unknown

20 enrolled

Endocrine

Carcinoid Heart Disease, Carcinoid Tumor, Serotonin Syndrome

NCT02299089 2017-12-15

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Phase 2 Completed

12 enrolled 18 charts

EndocrineNET

Acromegaly, Neuroendocrine Tumors, Serotonin Syndrome

NCT01172717 2013-07-26

Study of Panitumumab in the Treatment of Carcinoid Syndrome

Phase 2 Withdrawn

Endocrine

Carcinoid Tumor, Serotonin Syndrome

NCT00088595 2012-06-04

Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors

Phase 2 Completed

45 enrolled 10 charts

Endocrine

Carcinoid Tumor, Serotonin Syndrome